ym 09151-2 has been researched along with quinolinic acid in 1 studies
| Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (quinolinic acid) | Trials (quinolinic acid) | Recent Studies (post-2010) (quinolinic acid) |
|---|---|---|---|---|---|
| 249 | 6 | 13 | 1,856 | 19 | 472 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Hayakawa, N; Ishiwata, K; Nagaoka, T; Oda, K; Ogi, N; Senda, M; Tanaka, A; Toyama, H; Umegaki, H | 1 |
1 other study(ies) available for ym 09151-2 and quinolinic acid
| Article | Year |
|---|---|
Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone.
Topics: Animals; Autoradiography; Benzamides; Dopamine Antagonists; Glucose; Magnetic Resonance Imaging; Male; Neostriatum; Neurotoxins; Quinolinic Acid; Raclopride; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, GABA-A; Spiperone; Tomography, Emission-Computed | 2002 |